November 14, 2007

Bioident Executive to speak at SMALL TIMES NanoCon International

English Version 97.05 Kb

 

Menlo Park, California – November 14, 2007
Wasiq Bokhari, CEO of BIOIDENT Technologies, will be participating in a panel discussion on “Enabling New Applications through Nano-printing and Lithography Technologies” at the Small Times NanoCon International Conference, the leading nanotechnology and MEMS networking event, taking place November 14-16, 2007 at the Santa Clara Convention Center in Santa Clara, Calif. Mr. Bokhari has extensive entrepreneurial experience in adoption and commercialization of emerging materials and nanotechnology and will speak specifically about how these technologies are enabling new life sciences applications.

The panel discussion, moderated by Tom Cheyney, senior contributing editor at Small Times, will provide an overview of how nanoprinting and nanolithography offer a number of benefits over traditional methods of device fabrication, including simplicity and low cost. The techniques have been used in electrical, optical, photonic and biological applications and have, in some cases, enabled the creation of more efficient devices. The panel will explore the different approaches, as well as technology and process advances—all with an eye toward impacts they are making or promising in terms of product development, commercialization, and new application opportunities. In addition, the panel will take a peek into the future to predict the expansion and impact of bottom-up approaches.

Joining Mr. Bokari on the panel will be representatives of FUJIFILM Dimatix, Inc., Obducat and Molecular Imprints.


Location:
Santa Clara Convention Center
Santa Clara, CA

Date/Time:
Wednesday, November 14, 2007
1:30-3:00 p.m. PT


Bringing together more than 400 nanotechnology and MEMS professionals and decision makers from around the world, Small Times NanoCon International is the premier event for business alliances, information exchange and commercial strategy. Participants will address the latest trends and issues affecting the commercialization of nanotechnology and MEMS, and exhibits will feature the leading tools, manufacturing, materials and service companies.

About Wasiq Bokhari

Bokhari is a co-founder and managing partner of Quantum Insight. He works with Fortune 500 companies on the adoption and commercialization of materials and nanotechnology with applications in energy, IT and medicine. Bokhari also works with entrepreneurs and early-stage startups in technology commercialization.
He is a serial entrepreneur with extensive experience in the field of emerging materials and nanotechnology. He serves as a strategic advisor to Chevron and is part of the team that has built and grown Molecular Diamond Technologies, a new nanomaterials focused business unit. He also serves as a strategic advisor to Hitachi in the areas of emerging electronics, energy and life sciences applications. Bokhari was part of the founding team and interim CEO of Kalinex Inc., a drug discovery instrumentation company. Prior to that, he was part of the founding team and Senior Vice President of Products of Clickmarks, an enterprise infrastructure software company, subsequently acquired by Semotus Solutions.
Bokhari received his Ph.D. in physics from the Massachusetts Institute of Technology, under Nobel Laureate Jerome Friedman. He was part of the team that discovered a fundamental particle called the top quark at the Fermi National Accelerator Laboratory in 1995. He is an author of more than 50 scientific and technical publications, and is cited as an inventor on eight patents, granted and applied. He is also the co-founder and Steering Committee Chair of the MIT Stanford UC Berkeley Nanotechnology Forum. Bokhari has worked with PCAST (Presidential Council of Advisors on Science and Technology) on issues related to energy. PCAST is the highest civilian body that advises the US President on issues in science and technology.

About BIOIDENT Technologies Inc.
BIOIDENT is the leader in the development of rapid, multi-assay and mobile analytical and diagnostic systems. BIOIDENT integrates highly sensitive printed photodetectors and electronics with various existing Lab-on-a-Chip (LOC) technologies including lateral flow, microfluidics and microarrays. BIOIDENT’s systems are designed for applications in in-vitro diagnostics, chemical and biological threat detection, and environmental testing. BIOIDENT’s award-winning Photonic Lab™ Technology Platform eliminates the need for complex and expensive readout systems and delivers unprecedented mobility and sensitivity based on existing biological and chemical assays. Benefits for BIOIDENT’s customers and partners include high mobility, rapid testing, multiplexing and low cost of ownership.
BIOIDENT is a subsidiary of Austrian-based NANOIDENT Technologies AG, the world leader in printed opto-electronics. The company is privately held with headquarters in Menlo Park, California. BIOIDENT leverages NANOIDENT’s SEMICONDUCTOR 2.0™ Platform technology and its high-speed manufacturing process, which uses liquid conductive and semi-conductive materials to print electronic circuits on almost any surface using an inkjet printer. NANOIDENT also has the world’s only dedicated organic fabrication facility with a production output of 40,000 sq.m per year. For more information about the company, please visit www.bioident.com or www.nanoident.com

wasiq_105x75.jpg


Download Image
Image Text:

Dr. Wasiq Bokhari, CEO BIOIDENT Technologies Inc.

 
For more artwork, please visit our Download-Area!
Last Updated ( Tuesday, 22 January 2008 )
 
© 2008 NANOIDENT Technologies AG